Early percutaneous thrombolysis for AVF thrombosis: symptom duration as a predictor of endovascular salvage
Yazarlar (2)
Doç. Dr. İsmail TAŞKENT Kastamonu Üniversitesi, Türkiye
Doç. Dr. Güler Gülsen ERSOY Kastamonu Üniversitesi, Türkiye
| Makale Türü |
Özgün Makale
(ESCI dergilerinde yayınlanan tam makale)
|
||
| Dergi Adı | Cvir Endovascular | ||
| Dergi ISSN | 2520-8934 Wos Dergi Scopus Dergi | ||
| Dergi Tarandığı Indeksler | ESCI | ||
| Makale Dili | İngilizce | Basım Tarihi | 08-2025 |
| Cilt / Sayı / Sayfa | 8 / 1 / 67–0 | DOI | 10.1186/s42155-025-00587-2 |
| Makale Linki | https://doi.org/10.1186/s42155-025-00587-2 | ||
| UAK Araştırma Alanları |
Radyoloji
|
||
| Özet |
| BackgroundArteriovenous fistula (AVF) thrombosis remains a critical complication in hemodialysis (HD) patients, often leading to treatment delays and requiring urgent intervention. While endovascular therapy (EVT) is commonly employed, less invasive strategies such as percutaneous thrombolytic therapy are gaining attention due to their potential to restore patency and avoid more complex procedures. This study assessed the effectiveness of percutaneous thrombolytic therapy in acute AVF thrombosis and explored key predictors associated with the need for subsequent endovascular intervention.MethodsThis retrospective study included 42 patients who underwent ultrasound-guided percutaneous thrombolytic therapy using low-dose alteplase (3–5 mg). Technical and clinical success, complication rates, and the need for additional EVT were assessed. Statistical analyses including logistic regression and ROC … |
| Anahtar Kelimeler |
| Arteriovenous fistula | Endovascular intervention | Hemodialysis | Percutaneous thrombolytic therapy | Thrombosis |
BM Sürdürülebilir Kalkınma Amaçları
| Atıf Sayıları | |
| Web of Science | 1 |
| Scopus | 1 |
| Google Scholar | 1 |